OTIFAES is a specialized line of otological (ear care) health products owned and marketed by the Spanish pharmaceutical company Faes Farma. The brand focus is on maintaining ear hygiene, preventing infections, and treating common ear canal issues such as wax accumulation and “swimmer’s ear”.

Core Product Portfolio

The OTIFAES line is developed through strategic partnerships, notably with Mitelos, to provide therapeutic alternatives in the Ear, Nose, and Throat (ENT) specialty. Key products include:

OTIFAES TaponOX:
An ear spray designed to disintegrate and dislodge earwax plugs. It uses an oil-free formula with 3% hydrogen peroxide, which releases oxygen to break wax into small fragments. It is formulated to maintain the ear’s slightly acidic physiological pH to prevent bacterial growth.

OTIFAES BoriSEC:
An otic spray used to prevent acute external otitis (swimmer’s ear). It contains 3% boric acid, ethanol, and glycerin to help dry excess moisture in the ear canal after water activities or exposure to high humidity.

OTIFAES CalmaDOL:
Otic drops intended for the rapid relief of pain and itching in the external auditory canal. It combines glycerol to reduce inflammation and lidocaine as a local anesthetic for immediate pain relief.

Brand Positioning and Safety

Target Audience:
The products are generally indicated for adults and children (CalmaDOL is suitable from 6 months, while Borisec and Taponox have specific age recommendations or warnings for younger children). Taponox is especially recommended for hearing aid users, the elderly, and those with narrow ear canals.

Safety Precautions:
OTIFAES products are for external otic use only. They should not be used by individuals with perforated eardrums, ear discharge, tinnitus (ringing), or a history of significant ear surgery.

Manufacturing Standards:
Developed under high-quality pharmaceutical standards in Spain, the brand emphasizes ergonomic packaging and precise dosing through pump dispensers.